Natco Pharma

BSE: 524816 | NSE: NATCOPHARM
Natco Pharma (CIN: L24230TG1981PLC003201) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Apr 1995. It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills,Hyderabad,Telangana,500033.

The management team of Natco Pharma is led by Mr. V C NANNAPANENI who is the Executive Director-Chairperson-MD. Other members of the management team consist of Mr. RAJEEV NANNAPANENI (Designation:Executive Director-CEO), S V V N Appa Rao (Designation:Chief Financial Officer), Mr. P S R K PRASAD (Designation:Executive Director), Mr. DR. D LINGA RAO (Designation:Executive Director), Mr. G S MURTHY (Designation:Non-Executive - Independent Director-Shareholder Director), Mr. D G PRASAD (Designation:Non-Executive - Independent Director-Shareholder Director), Mr. T V RAO (Designation:Non-Executive - Independent Director-Shareholder Director), Mr. DR. M U R NAIDU (Designation:Non-Executive - Independent Director-Shareholder Director), Mrs. DR. LEELA DIGUMARTI (Designation:Non-Executive - Independent Director-Shareholder Director), Mr. SRIDHAR SANKARARAMAN (Designation:Non-Executive - Non Independent Director), M Adinarayana (Designation:Company Secretary & Vice President (Legal & Corporate Affairs)), .

The price and other financial information of Natco Pharma is as below -

BSE 885.55 25.35 (2.95%)

BSE

885.55 25.35 (2.95%)
Volume: 49,330.00
M. Cap: 16,135.00
P/E: 35.55
Prev. Close: 852.20
Day
52 Wk
Symbol is not Traded Today for NSE

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 8,90,85,045 48.93
Foreign Institutions 3,71,46,362 20.40
NBFC and Mutual Funds 1,57,93,215 8.67
Others 52,18,150 2.87
General Public 2,72,73,451 14.98
Financial Institutions 75,51,752 4.15
Total 18,20,67,975 100

Financial Data

Consolidated
Figures in crore 2020 2019 2018
Net Sales 1,915.00 2,094.50 2,184.80
Operating Profit 690.00 925.00 968.80
Other Income 107.40 130.20 40.40
Interest 21.50 19.30 15.40
Depreciation 99.80 81.00 66.20
Profit Before Tax 568.70 824.70 887.20
Tax 110.60 182.30 192.00
Profit After Tax 458.10 642.40 695.20
Share Capital 36.40 36.50 36.90
Reserves 3,737.10 3,452.50 3,035.30
Net Worth 3,773.50 3,489.00 3,072.20
Loans 406.90 458.10 206.40
Gross Block 2,148.70 1,694.50 1,407.60
Investments 112.30 168.60 76.50
Cash 66.00 279.50 183.70
Debtors 551.30 506.20 637.50
Net Working Capital 1,976.90 1,915.70 1,707.30
Operating Profit Margin (%) 36.03 44.16 44.34
Net Profit Margin (%) 23.92 30.67 31.82
Earning Per Share (Rs) 25.32 35.31 37.73
Dividend (%) 337.50 312.50 412.50
Dividend Payout 127.40 91.90 150.90
Standalone
Figures in crore 2020 2019 2018
Net Sales 1,790.20 1,986.30 2,091.30
Operating Profit 701.80 946.30 967.80
Other Income 123.80 129.80 39.40
Interest 20.60 18.80 14.70
Depreciation 98.10 80.10 65.50
Profit Before Tax 583.10 847.40 887.60
Tax 108.60 180.30 189.40
Profit After Tax 474.50 667.10 698.20
Share Capital 36.40 36.50 36.90
Reserves 3,833.10 3,526.70 3,088.50
Net Worth 3,869.50 3,563.20 3,125.40
Loans 405.00 456.30 206.20
Gross Block 2,133.70 1,678.20 1,399.60
Investments 191.10 244.40 149.60
Cash 54.10 262.70 172.10
Debtors 536.70 491.60 606.00
Net Working Capital 1,991.10 1,922.70 1,686.70
Operating Profit Margin (%) 39.20 47.64 46.28
Net Profit Margin (%) 26.51 33.59 33.39
Earning Per Share (Rs) 26.07 36.55 37.84
Dividend (%) 337.50 312.50 412.50
Dividend Payout 127.40 91.90 150.90
Dividend Declared (₹)
The company has declared dividend 21 times between 12 Nov 2007 and 21 Aug 2020, totaling Rs. 50.00 so far. The most recent dividend was declared on 21 Aug 2020 for Rs. 1.25.

Financial Data Graph

The peers of Natco Pharma are AUROPHARMA, NECLIFE and PFIZER. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.